4,996
Views
21
CrossRef citations to date
0
Altmetric
Editorial

Leveraging the attributes of biologics and small molecules, and releasing the bottlenecks: a new wave of revolution in drug development

&
Pages 747-749 | Received 05 Feb 2016, Accepted 29 Feb 2016, Published online: 16 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amelia Stennett, Kallie Friston, Claire L. Harris, Adam J. M. Wollman, Agnieszka K. Bronowska & Katrina S. Madden. (2023) The case for complement component 5 as a target in neurodegenerative disease. Expert Opinion on Therapeutic Targets 27:2, pages 97-109.
Read now

Articles from other publishers (20)

Jennifer E. Collins, Jin Woo Lee, Frances Rocamora, Gagandeep S. Saggu, Karen L. Wendt, Charisse Flerida A. Pasaje, Sebastian Smick, Natalia Mojica Santos, Raphaella Paes, Tiantian Jiang, Nimisha Mittal, Madeline R. Luth, Taylor Chin, Howard Chang, James L. McLellan, Beatriz Morales-Hernandez, Kirsten K. Hanson, Jacquin C. Niles, Sanjay A. Desai, Elizabeth A. Winzeler, Robert H. Cichewicz & Debopam Chakrabarti. (2023) Antiplasmodial peptaibols act through membrane directed mechanisms. Cell Chemical Biology.
Crossref
Linghui Qian, Xuefen Lin, Xue Gao, Rizwan Ullah Khan, Jia-Yu Liao, Shubo Du, Jingyan Ge, Su Zeng & Shao Q. Yao. (2023) The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics. Chemical Reviews 123:12, pages 7782-7853.
Crossref
Lisa Benedetta De Martini, Claudia Sulmona, Liliana Brambilla & Daniela Rossi. (2023) Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs. Cells 12:12, pages 1643.
Crossref
Jacek Plichta, Piotr Kuna & Michał Panek. (2023) Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives. Frontiers in Immunology 14.
Crossref
Diana Rafael, Marcelo Guerrero, Adolfo Marican, Diego Arango, Bruno Sarmento, Roser Ferrer, Esteban F. Durán-Lara, Simon J. Clark & Simo SchwartzJr.Jr.. (2023) Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds. Pharmaceutics 15:5, pages 1484.
Crossref
Kevin Y. Wu, Maxine Joly-Chevrier, Dania Akbar & Simon D. Tran. (2023) Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems. Pharmaceutics 15:4, pages 1094.
Crossref
Michael Y.T. Chow, Harry W. Pan & Jenny K.W. Lam. 2023. Pulmonary Pharmacology. Pulmonary Pharmacology 273 311 .
G. Gedik, C. K. Oztabag, O. Sarp, H. Nazli, G. Tiranbesli, A. H. Kurt, E. Dinc & L. Ayaz. (2022) Development of Anti-VEGF Prolonged Release Drug Delivery System Containing PLL Dendrimer and Hyaluronic Acid. Russian Journal of Bioorganic Chemistry 48:6, pages 1348-1361.
Crossref
Floris Dammeijer, Mandy van Gulijk, Larissa Klaase, Menno van Nimwegen, Rachid Bouzid, Robin Hoogenboom, Maria E. Joosse, Rudi W. Hendriks, Thorbald van Hall & Joachim G. Aerts. (2022) Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy. Molecular Cancer Therapeutics 21:9, pages 1393-1405.
Crossref
Esben Malm, Sabrina Mai Nielsen, Johannes Berg, John P. A. Ioannidis, Daniel Furst, Josef S. Smolen, Peter C. Taylor, Lars Erik Kristensen, Simon Tarp, Torkell Ellingsen & Robin Christensen. (2021) Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors. BMJ Open 11:9, pages e049850.
Crossref
Masahito SatoSatoshi TakeuchiShinji SogaKoji AoyamaJotaro Suzuki. (2020) Generation and Characterization of a Novel Anti-Rat TLR4/MD2 Antibody with Potent Neutralizing Activity In Vivo . Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 39:6, pages 217-221.
Crossref
Nahla Jemni-Damer, Atocha Guedan-Duran, María Fuentes-Andion, Nora Serrano-Bengoechea, Nuria Alfageme-Lopez, Felix Armada-Maresca, Gustavo V. Guinea, José Pérez-Rigueiro, Francisco Rojo, Daniel Gonzalez-Nieto, David L. Kaplan & Fivos Panetsos. (2020) Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Ana Maria M. M. Faisca Phillips. 2020. Synthetic Approaches to Nonaromatic Nitrogen Heterocycles. Synthetic Approaches to Nonaromatic Nitrogen Heterocycles 1 20 .
Mohamed Hassanein, Michael A Partridge, Weiping Shao & Albert Torri. (2020) Assessment of clinically relevant immunogenicity for mAbs; are we over reporting ADA?. Bioanalysis 12:18, pages 1325-1336.
Crossref
Ivan Seah, Xinxin Zhao, Qianyu Lin, Zengping Liu, Steven Zheng Zhe Su, Yew Sen Yuen, Walter Hunziker, Gopal Lingam, Xian Jun Loh & Xinyi Su. (2020) Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases. Eye 34:8, pages 1341-1356.
Crossref
Andrew Mtewa, Duncan C. Sesaazi & Fanuel Lampiao. (2020) Structural and In Silico Characterization of Small Molecules Isolated from Eichhornia crassipes . Evidence-Based Complementary and Alternative Medicine 2020, pages 1-11.
Crossref
Attapol Kamthong, Phenbunya Boonyalekha, Jeerapond Leelawattanachai & Waraho-Zhmayev Dujduan. (2020) Application of the Synthetic Escherichia coli’s Twin-Arginine Translocation Pathway for the Detection of Intracellular Antibodies against Hepatitis C Viral Protease. International Journal of Bioscience, Biochemistry and Bioinformatics 10:1, pages 49-57.
Crossref
Sheila Dakhel, Tiziano Ongaro, Baptiste Gouyou, Mattia Matasci, Alessandra Villa, Dario Neri & Samuele Cazzamalli. (2019) Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade. Oncotarget 10:62, pages 6678-6690.
Crossref
Wei Li, Iok-Hou Pang, Mario Thiego F. Pacheco & Hong Tian. (2018) Ligandomics: a paradigm shift in biological drug discovery. Drug Discovery Today 23:3, pages 636-643.
Crossref
J.F. Buyel, R.M. Twyman & R. Fischer. (2017) Very-large-scale production of antibodies in plants: The biologization of manufacturing. Biotechnology Advances 35:4, pages 458-465.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.